The immunological interactions that regulate the T-cell response to chronic viral infection are insufficiently understood. Here we study a cellular interaction that may enhance the antiviral immune response and constrain immunopathology. We analyze the contribution of Qa-1-restricted CD8 + regulatory T cells (Treg cells) to antiviral immunity after infection by lymphocytic choriomeningitis virus. These CD8 + Treg cells recognize and eliminate target cells through an interaction with the murine class Ib MHC molecule Qa-1 (HLA-E in humans). Using Qa-1 mutant mice (B6.Qa-1-D227K [B6-DK]) that harbor a single mutation that abrogates binding of Qa-1 peptide to the CD8-TCR (T-cell receptor) complex, we show that disruption of immune suppression mediated by CD8
The immunological interactions that regulate the T-cell response to chronic viral infection are insufficiently understood. Here we study a cellular interaction that may enhance the antiviral immune response and constrain immunopathology. We analyze the contribution of Qa-1-restricted CD8
+ regulatory T cells (Treg cells) to antiviral immunity after infection by lymphocytic choriomeningitis virus. These CD8 + Treg cells recognize and eliminate target cells through an interaction with the murine class Ib MHC molecule Qa-1 (HLA-E in humans). Using Qa-1 mutant mice (B6.Qa-1-D227K [B6-DK]) that harbor a single mutation that abrogates binding of Qa-1 peptide to the CD8-TCR (T-cell receptor) complex, we show that disruption of immune suppression mediated by CD8
+ Treg cells results in robust antiviral immune responses in both acute and chronic viral infection. Enhanced antiviral responses of B6-DK mice were accompanied by increased control of virus, reduced tissue inflammation in the acute phase, and dramatic alleviation of disease in the chronic phase. In addition, CD8
+ effector T cells in B6-DK mice displayed a less exhausted phenotype characterized by decreased expression of programmed cell death 1 (PD-1), LAG3 (CD223), and 2B4 (CD244) and increased expression of NKG2D (CD314) and killer cell lectin-like receptor subfamily G member 1 (KLRG1). Enhanced antiviral immunity in B6-DK mice reflected, in part, reduced inhibition of CD8 + effector cells by CD8 + Treg cells. These findings indicate that direct inhibition of effector CD8
+ T cells by Qa-1-restricted CD8 + Treg cells results in increased disease severity and delayed recovery. These data suggest that depletion or inactivation of CD8 + Treg cells represents a potentially effective strategy to enhance protective immunity to chronic viral infection.
T-cell exhaustion | killer cell Ig-like receptor | immune regulation V iral infection continues to be a major worldwide health burden, as indicated by recent estimates that more than 500 million people suffer from chronic viral hepatitis B and C (1) . Although vaccines have led to the eradication of smallpox (2) and the prevention of many other viral infections, major obstacles to progress include an incomplete understanding of the interactions between the immune system and viral pathogens that underlie viral evasion, T-cell exhaustion, and immunopathology (3) . Further definition of immunological mechanisms that promote robust antiviral immune responses with minimal host tissue damage requires a better understanding of the host immune response during the progression, spread, and clearance of virus (4, 5) .
Lymphocytic choriomeningitis virus (LCMV) is a widely used disease model for studies of the immune response to viral infection (6) . LCMV-Armstrong (Arm), first described in the 1930s after an encephalitis epidemic in St. Louis, Missouri (7) , results in an acute viral infection, the rapid resolution of which depends largely on an efficient, virus-specific CD8 + cytotoxic T-cell response. Although LCMV-Arm is noncytopathic, an excessive host immune response to the virus can lead to severe tissue damage, including inflammatory hepatitis and pneumonitis (8, 9) . The LCMV strain clone 13 (LCMV-Cl13) is a genetic variant of LCMV-Arm that can persist in the host as a chronic infection (10) , which is marked by CD8 + T-cell exhaustion, continued tissue inflammation, and destruction (11, 12) .
The role of regulatory T cells during viral infection has been the subject of studies aimed at understanding mechanisms that control this process. The majority of these studies in both mice and humans have focused on CD4 + CD25 + FoxP3 + (forkhead box P3) regulatory T cells (Treg cells) (13) . Coevolution of microorganisms and CD4
+ Treg cells have led to a range of outcomes, including protection of the host through inhibition of collateral inflammatory damage as well as exacerbation of disease through promotion of pathogen persistence (13) . The contribution of CD4 + Treg cells to the outcome of LCMV infection has not been clearly defined (14) (15) (16) .
In addition to FoxP3 + CD4 + cells, a regulatory lineage within the CD8 + T-cell subset has recently been identified (17) . CD8
+ Treg cells display a memory phenotype and express CD44 and CD122 receptors along with the natural killer (NK) cell receptor Ly49. This small subset of CD8 + T cells is IL-15-dependent and is essential for both maintenance of self-tolerance and prevention of autoimmune disease in mice (18) . CD8
+ Treg cells target mainly CD4
+ follicular T-helper cells through recognition of the murine class Ib MHC molecule Qa-1, resulting in perforin-dependent elimination and diminished autoimmune responses (18) . This analysis is based in part on the generation of Qa-1 knock-in mice that harbor a single D→K amino acid exchange point mutation at position 227 [B6.Qa-1-D227K (B6-DK)] that abrogates binding of Qa-1 peptide to the CD8-TCR complex (19) . B6-DK mutant mice develop severe autoimmune disease marked by the generation of autoantibodies to multiple tissues, lymphocyte infiltration into nonlymphoid tissues, and lethal glomerulonephritis (19) . The contribution of CD8 + Treg cells to the antiviral immune response has not been directly examined.
Here we find that CD8 + Treg cells inhibit the immune response to LCMV infection. Effector T cells are suppressed by Significance Cellular interactions that regulate the immune response of T cells to viral infection are poorly understood. Here we report that in the absence of activity of CD8 regulatory T-cells (CD8 Treg cells), antiviral immunity is enhanced and the deleterious effects of viral infection are constrained. Using a genetically modified mouse model that displays defective regulatory activity of CD8 Treg cells, the immune response against viruses was substantially enhanced during the acute and chronic phase of viral infection; this enhanced antiviral response prevented tissue damage associated with viral infection. This suggests that protective immunity to viral infection can be achieved by blocking the inhibitory effects of CD8 Treg cells and opens the possibility of unique approaches to treat viral infection.
Qa-1-restricted CD8
+ Treg cells during both acute and chronic LCMV infection. 
effector CD8
+ T cells were approximately threefold higher in B6-DK mice compared with B6-WT mice by day 3 after infection; this increase persisted through the immune response at day 8 (Fig. 1B) . We also analyzed killer cell lectin-like receptor subfamily G member 1 (KLRG1) +
CD127
-CD8 + T cells, which are "short-lived effector cells" (SLECs) that can contribute to the early adaptive antiviral immune response. By day 5-8 after infection, B6-DK mice displayed an approximate fivefold increase in LCMV-specific SLECs (gp33-tetramer
KLRG1
+ CD8 + ) compared with wild-type mice (Fig. 1C) . We then asked whether enhanced CD8 + T-cell responses during acute viral infection secondary to genetic disruption of Qa-1-restricted CD8 + Treg cells activity was associated with enhanced CD8
+ functional activity. Cytotoxic activity of effector CD8 + T cells toward target cells was mediated in part by upregulated perforin and granzymes. Assessment of granzyme B in LCMV-specific gp33-tet
cells ex vivo 8 d after infection with LCMV-Arm revealed elevated granzyme B expression in B6-DK CD8
+ T-cells consistent with more efficient effector T-cell responses compared with B6-WT mice (Fig. 1D ). Expression of IFN-γ, an additional hallmark of protective CD8 + T-cell responses to viral infection, was increased in B6-DK CD8 + T cells (Fig. 1E ).
Increased Virus-Specific CD8 T Cells on Chronic LCMV Infection of B6-DK Mice. Next we asked whether enhanced CD8 + T-cell immunity could influence chronic infection. B6-WT and B6-DK mice were inoculated with LCMV-Cl13 to produce a chronic viral infection, and the antiviral immune response was evaluated at the early (day 10) and late (day 45-55) stages of disease. We noted that B6-DK mice developed enhanced immune responses during chronic viral infection, as noted earlier for acute LCMV infection. The LCMV-specific CD8 + T-cell response was increased in B6-DK mice by day 10 and became more pronounced at later stages of chronic infection ( Fig. 2A) . Effector CD8 + T-cell activity was also increased in B6-DK mice, as judged from enhanced intracellular expression of IFN-γ, granzyme B, and CD107a by CD8
+ cells (Fig. 2B) . Moreover, B6-DK mice harbored increased proportions of CD8 + T cells that coexpressed either two or all three markers of effector function (Fig. 2B) .
Advanced chronic LCMV-Cl13 viral infection is accompanied by effector CD8 + T cells that display an exhausted phenotype and poor effector function and express higher levels of inhibitory receptors. We asked whether the elevated cellular immune response of B6-DK mice was associated with reduced levels of exhausted CD8 + T cells. We compared LCMV-specific gp33-tet
cells from B6-WT and B6-DK mice 45 d after infection with LCMV clone 13. LCMV-specific CD8
+ T cells from B6-DK mice expressed a phenotype skewed toward fully functioning memory cells, whereas CD8
+ T-cells from B6-WT mice displayed a phenotype more characteristic of exhausted CD8 + T cells (Fig. 2C ) (21) . LCMV-specific CD8 + T cells from B6-WT mice expressed elevated levels of the inhibitory receptors LAG-3 (CD223), PD-1 (programmed cell death 1), and 2B4 (CD244) and reduced levels of activating receptors NKG2D (CD314) and KLRG1 compared with LCMV-specific CD8 + cells from B6-DK mice (Fig. 2C) . B6-DK effector CD8 + T cells also expressed reduced levels of Eomesodermin, a transcription factor expressed by exhausted CD8 + T cells (Fig. 2D ). Further analysis revealed that B6-DK KLRG1 + effector CD8 + T cells expressed reduced levels of inhibitory receptors (SI Appendix, Fig. S1 ). Increased expression of IFN-γ by B6-DK mice at the late stage of infection (day 45) was consistent with the observation that virus-specific CD8 + T cells in B6-DK mice display a less exhausted phenotype (Fig. 2E) . + T-cell responses that were not accompanied by significant tissue pathology. In contrast, the weaker B6-WT CD8 T-cell response was accompanied by severe pneumonitis and hepatitis characterized by strong leukocyte infiltration into these organs (Fig. 3A) . Measurement of leukocyte infiltrates revealed an approximate fivefold increase in lungs and a >10-fold increase in the liver of B6-WT mice compared with B6-DK mice. The inflammatory changes observed in WT mice may be a result of reduced clearance of virus, as their relatively inefficient CD8 + T-cell response was associated with increased serum virus titers on day 5 after LCMV-Arm infection (Fig. 3B) . These data suggest that enhanced antiviral responses in mice secondary to genetic disruption of CD8 + Treg cell activity allowed more efficient viral clearance and decreased tissue pathology. of disease, tissue pathology, and viral titers of B6-WT and B6-DK mice after LCMV-Cl13 infection. Body weight measurements showed no difference between B6-WT and B6-DK mice during the early phase of infection (Fig. 4A) . Around day 10, however, B6-DK mice began to gain weight and show signs of recovery, whereas weight loss in WT mice continued until day 20 (Fig. 4A) . A more comprehensive approach to evaluate the clinical disease status depended on illness scores. B6-DK mice showed reduced levels of disease intensity and an accelerated recovery and were free of clinical symptoms by day 23, whereas WT mice remained moderately ill and did not fully recover (Fig. 4B) . A similar pattern was observed for viral titers and tissue pathology. Both groups showed severe tissue pathology in lung and liver in the early stage of chronic disease with highly active pneumonitis and hepatitis. However, by day 55 postinfection, lung and liver showed no sign of pathological changes in B6-DK mice, whereas WT mice displayed immune cell infiltration and histopathology (Fig. 4C) . Consistent with these histological findings at late stages of chronic infection, significant reduction of viral titers was seen in organs of B6-DK mice compared with B6-WT mice (Fig. 4D) . 
CD8
+ T-cell response was measured. Reduced CD8 + T-cell responses were observed after cotransfer of Ly49 +
+ Treg cells and WT CD8 + target cells, but not B6-DK CD8 effector cells (Fig. 5A) .
We then examined the effect of CD8 + Treg cells on virusspecific CD8 + T cells, using transgenic mice that express a TCR specific for LCMV viral epitope gp33 associated with H-2D b (P14 mice) (22 + T-cell numbers and dye dilution revealed that B6-DK LCMV-specific CD8 + T cells underwent strong proliferation detected by Celltrace Violet dilution, whereas the level of proliferation by B6-WT P14 CD8
+ cells was significantly reduced (Fig. 5B) . These data indicate that Qa-1-restricted inhibition of LCMV-specific responses by CD8 + cells reflects, at least in part, direct targeting of LCMV-specific CD8
+ cells by CD8 + Treg cells. 
CD25
+ Treg cells can also lead to enhanced pathogen survival and persistence in some cases (24, 25) and can allow immune evasion (26) . Understanding the mechanisms that underlie the protective and pathogenic effects of CD4 + Treg cells (17, 33) and lead to more direct approaches to defining the contribution of CD8 + Treg cells to the human antiviral immune response.
Definition of specific KIR subtypes expressed by human CD8 cells that display HLA-E-dependent inhibitory activity may allow development of KIR-specific Abs that interrupt CD8
+ Treg cellmediated suppression in the setting of established disease. This approach may allow therapeutic intervention during the course of disease, rather than simply a potential preventative measure. Because HLA-E (Qa-1) is up-regulated by activated effector cells, antibody blockade of HLA-E (Qa-1)-restricted suppression by CD8 Treg cells may allow rescue of effector cells and enhanced antiviral activity during the course of a chronic infection. In contrast to other therapeutic approaches, such as immune checkpoint blockade and CD4 + Treg cell depletion, selective enhancement of antiviral effector cells after interruption of CD8 + Treg cell-mediated suppression may avoid nonspecific activation that can lead to an autoimmune response.
In sum, these findings extend previous analyses suggesting that Qa-1-restricted CD8
+ Treg cells regulate a wide range of immune responses to include chronic viral infections. Additional analysis of this inhibitory interaction may yield new approaches to regulate antiviral immunity.
Methods
Animals. C57BL/6 and Thy1.1 + mice (B6.PL-Thy1a/CyJ) were purchased from Jackson Laboratory, and Rag2 −/− (B6.129S6-Rag2tm1Fwa N12) mice were purchased from Taconic Farms. B6.Qa-1-D227K (B6-DK) mice were generated as described previously (19 
IMMUNOLOGY
Viral Infection. Age-and sex-matched animals were infected intraperitoneally with 2 × 10 5 pfu LCMV-Arm (acute) or i.v. with 1 × 10 6 pfu LCMV clone 13 (chronic). LCMV clone 13 and Arm were propagated on BHK cells, as previously described (34) . After infection, mice were weighed daily, and body weight was calculated as a percentage of initial weight on day 0. Illness scores were measured by giving 1 point for each of the following conditions: ruffled fur, weight loss exceeding 15%, visually lethargic, lethargic to the touch, and a hunched back (35) . Virus titers were assessed by plaque assay on Vero cells (36) after lysing whole organs, using a Qiagen TissueLyser II according to the manufacturer's instructions. For intracellular staining, splenocytes were incubated in RPMI medium (supplemented with FCS, penicillin-streptomycin, sodium pyruvate, Hepes buffer, and L-glutamine) for 3 h with either 1 μg/mL glycoprotein 33-41 (GP [33] [34] [35] [36] [37] [38] [39] [40] [41] ) peptide or 50 ng/mL phorbol 12-myristate 13-acetate (PMA) + 500 ng/mL ionomycin in the presence of 3 μg/mL brefeldin and 2 μM monensin (BD Biosciences). For degranulation assays, anti-CD107a antibody was also present during stimulation. After incubation, viability, surface, and intracellular staining were performed using a BD cytofix/cytoperm kit, according to manufacturer's instructions, using the following antibodies: anti-granzyme-B (GB11), anti-IFN-γ (XMG1.2), anti-CD107a (1D4B), anti-Eomes (Dan11mag), Celltrace Violet, and fixable viability dye.
Histology. At individual points, mice were killed and organs were immediately fixed in Bouin's solution or snap frozen in O.C.T. Compound (Tissue-Tek) before sectioning and staining. More than 5 sections of each sample were analyzed by microscopy, and cell numbers were counted per field. Statistical Analyses. Statistical analyses were performed using Student's t test or Mann-Whitney test for comparison of two conditions. Error bars denote mean ± SD. A P value of <0.05 was considered to be statistically significant (*P < 0.05; **P < 0.005; ***P < 0.0005).
